NASDAQ:MBX - Nasdaq - US55287L1017 - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 84.89M | 35.31M | 25.16M | |||
Research and Development | 70.73M | 28.53M | 21.40M | |||
Selling, General, and Administrative Expenses | 14.17M | 6.78M | 3.76M | |||
Operating Income | -84.89M | -35.31M | -25.16M | |||
Interest Income/Expense | 6.00M | 2.75M | -75.00K | |||
Non Recurring Items | N/A | 0.00 | -899.00K | |||
Income Before Taxes | -78.90M | -32.56M | -26.14M | |||
Net Income | -78.90M | -32.56M | -26.14M | |||
EBITDA | -84.63M | -35.15M | -25.10M | |||
Per Share Data | ||||||
EPS Diluted Total Ops | -2.46 | -1.02 | -0.82 | |||
Statistics |
All data in USD